Uncertainty in Pharmacology : Epistemology, Methods, and Decisions / / edited by Adam LaCaze, Barbara Osimani.
This volume covers a wide range of topics concerning methodological, epistemological, and regulatory-ethical issues around pharmacology. The book focuses in particular on the diverse sources of uncertainty, the different kinds of uncertainty that there are, and the diverse ways in which these uncert...
Saved in:
Superior document: | Boston Studies in the Philosophy and History of Science, 338 |
---|---|
HerausgeberIn: | |
Place / Publishing House: | Cham : : Springer International Publishing :, Imprint: Springer,, 2020. |
Year of Publication: | 2020 |
Edition: | 1st ed. 2020. |
Language: | English |
Series: | Boston Studies in the Philosophy and History of Science,
338 |
Physical Description: | 1 online resource (475 pages). |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993548246504498 |
---|---|
ctrlnum |
(CKB)4100000010473822 (MiAaPQ)EBC6121699 (DE-He213)978-3-030-29179-2 (oapen)https://directory.doabooks.org/handle/20.500.12854/71573 (EXLCZ)994100000010473822 |
collection |
bib_alma |
record_format |
marc |
spelling |
La Caze, Adam edt Uncertainty in Pharmacology [electronic resource] : Epistemology, Methods, and Decisions / edited by Adam LaCaze, Barbara Osimani. 1st ed. 2020. Springer Nature 2020 Cham : Springer International Publishing : Imprint: Springer, 2020. 1 online resource (475 pages). text txt rdacontent computer c rdamedia online resource cr rdacarrier Boston Studies in the Philosophy and History of Science, 0068-0346 ; 338 Includes bibliographical references. This volume covers a wide range of topics concerning methodological, epistemological, and regulatory-ethical issues around pharmacology. The book focuses in particular on the diverse sources of uncertainty, the different kinds of uncertainty that there are, and the diverse ways in which these uncertainties are (or could be) addressed. Compared with the more basic sciences, such as chemistry or biology, pharmacology works across diverse observable levels of reality: although the first step in the causal chain leading to the therapeutic outcome takes place at the biochemical level, the end-effect is a clinically observable result—which is influenced not only by biological actions, but also psychological and social phenomena. Issues of causality and evidence must be treated with these specific aspects in mind. In covering these issues, the book opens up a common domain of investigation which intersects the deeply intertwined dimensions of pharmacological research, pharmaceutical regulation and the related economic environment. The book is a collective endeavour with in-depth contributions from experts in pharmacology, philosophy of medicine, statistics, scientific methodology, formal and social epistemology, working in constant dialogue across disciplinary boundaries. Part I. Epistemology -- 1. Defining Aspects of Mechanisms: Evidence-Based Mechanism (Evidence for a Mechanism), Mechanism-Based Evidence (Evidence from a Mechanism), and Mechanistic Reasoning -- 2. Causal Insights from Failure: Post-Marketing Risk Assessment of Drugs as aWay to Uncover Causal Mechanisms -- 3. Extrapolating from Model Organisms in Pharmacology -- 4. "Mechanistic Versus Statistical Extrapolation in Preclinical Research in Psychiatry: Challenging the Received View" -- 5. Analogy-Based Inference Patterns in Pharmacological Research -- 6. "In Silico Clinical Trials: a Possible Response to Complexity in Pharmacology" -- 7. "Uncertainty in Drug Discovery: Strategies, Heuristics and Technologies" -- 8. “Caught in the Amber”: a Sketch of Chemical Underdetermination -- Part II. Methods -- 9. A Millian Look at the Logic of Clinical Trials -- 10. "Learning by Difference: Placebo Effects and Specific Efficacy in Pharmacological RCTs" -- 11. "An Evidence-Hierarchical Decision Aid for Ranking in Evidence-Based Medicine" -- 12. "Assessing Drug Safety Assessment: Metformin Associated Lactic Acidosis" -- 13. Robust Biomarkers: Methodologically Tracking Causal Processes in Alzheimer’s Measurement -- 14. "Modelling Individual Response to Treatment and its Uncertainty: a Review of Statistical Methods and Challenges for Future Research" -- Part III. Decisions -- 15. Values in Pharmacology -- 16. "Humbug, the Council of Pharmacy and Chemistry, and the Origin of “the Blind Test” of Therapeutic Efficacy" -- 17. On the Normative Foundations of Pharmaceutical Regulation -- 18. After Disclosure -- 19. Sex, Drugs, and how to Deal with Criticism—The Case of Flibanserin. English H2020 European Research Council Medicine—Philosophy. Medical ethics. Philosophy of Medicine. https://scigraph.springernature.com/ontologies/product-market-codes/E34030 Theory of Medicine/Bioethics. https://scigraph.springernature.com/ontologies/product-market-codes/H66000 Uncertainty Management in Pharmacology, Causality Medical Epistemology, 3-030-29178-2 LaCaze, Adam. editor. edt http://id.loc.gov/vocabulary/relators/edt Osimani, Barbara. editor. edt http://id.loc.gov/vocabulary/relators/edt |
language |
English |
format |
Electronic eBook |
author2 |
LaCaze, Adam. LaCaze, Adam. Osimani, Barbara. Osimani, Barbara. |
author_facet |
LaCaze, Adam. LaCaze, Adam. Osimani, Barbara. Osimani, Barbara. |
author2_variant |
c a l ca cal a l al a l al b o bo b o bo |
author2_role |
HerausgeberIn HerausgeberIn HerausgeberIn HerausgeberIn |
author_sort |
LaCaze, Adam. |
title |
Uncertainty in Pharmacology Epistemology, Methods, and Decisions / |
spellingShingle |
Uncertainty in Pharmacology Epistemology, Methods, and Decisions / Boston Studies in the Philosophy and History of Science, Part I. Epistemology -- 1. Defining Aspects of Mechanisms: Evidence-Based Mechanism (Evidence for a Mechanism), Mechanism-Based Evidence (Evidence from a Mechanism), and Mechanistic Reasoning -- 2. Causal Insights from Failure: Post-Marketing Risk Assessment of Drugs as aWay to Uncover Causal Mechanisms -- 3. Extrapolating from Model Organisms in Pharmacology -- 4. "Mechanistic Versus Statistical Extrapolation in Preclinical Research in Psychiatry: Challenging the Received View" -- 5. Analogy-Based Inference Patterns in Pharmacological Research -- 6. "In Silico Clinical Trials: a Possible Response to Complexity in Pharmacology" -- 7. "Uncertainty in Drug Discovery: Strategies, Heuristics and Technologies" -- 8. “Caught in the Amber”: a Sketch of Chemical Underdetermination -- Part II. Methods -- 9. A Millian Look at the Logic of Clinical Trials -- 10. "Learning by Difference: Placebo Effects and Specific Efficacy in Pharmacological RCTs" -- 11. "An Evidence-Hierarchical Decision Aid for Ranking in Evidence-Based Medicine" -- 12. "Assessing Drug Safety Assessment: Metformin Associated Lactic Acidosis" -- 13. Robust Biomarkers: Methodologically Tracking Causal Processes in Alzheimer’s Measurement -- 14. "Modelling Individual Response to Treatment and its Uncertainty: a Review of Statistical Methods and Challenges for Future Research" -- Part III. Decisions -- 15. Values in Pharmacology -- 16. "Humbug, the Council of Pharmacy and Chemistry, and the Origin of “the Blind Test” of Therapeutic Efficacy" -- 17. On the Normative Foundations of Pharmaceutical Regulation -- 18. After Disclosure -- 19. Sex, Drugs, and how to Deal with Criticism—The Case of Flibanserin. |
title_sub |
Epistemology, Methods, and Decisions / |
title_full |
Uncertainty in Pharmacology [electronic resource] : Epistemology, Methods, and Decisions / edited by Adam LaCaze, Barbara Osimani. |
title_fullStr |
Uncertainty in Pharmacology [electronic resource] : Epistemology, Methods, and Decisions / edited by Adam LaCaze, Barbara Osimani. |
title_full_unstemmed |
Uncertainty in Pharmacology [electronic resource] : Epistemology, Methods, and Decisions / edited by Adam LaCaze, Barbara Osimani. |
title_auth |
Uncertainty in Pharmacology Epistemology, Methods, and Decisions / |
title_new |
Uncertainty in Pharmacology |
title_sort |
uncertainty in pharmacology epistemology, methods, and decisions / |
series |
Boston Studies in the Philosophy and History of Science, |
series2 |
Boston Studies in the Philosophy and History of Science, |
publisher |
Springer Nature Springer International Publishing : Imprint: Springer, |
publishDate |
2020 |
physical |
1 online resource (475 pages). |
edition |
1st ed. 2020. |
contents |
Part I. Epistemology -- 1. Defining Aspects of Mechanisms: Evidence-Based Mechanism (Evidence for a Mechanism), Mechanism-Based Evidence (Evidence from a Mechanism), and Mechanistic Reasoning -- 2. Causal Insights from Failure: Post-Marketing Risk Assessment of Drugs as aWay to Uncover Causal Mechanisms -- 3. Extrapolating from Model Organisms in Pharmacology -- 4. "Mechanistic Versus Statistical Extrapolation in Preclinical Research in Psychiatry: Challenging the Received View" -- 5. Analogy-Based Inference Patterns in Pharmacological Research -- 6. "In Silico Clinical Trials: a Possible Response to Complexity in Pharmacology" -- 7. "Uncertainty in Drug Discovery: Strategies, Heuristics and Technologies" -- 8. “Caught in the Amber”: a Sketch of Chemical Underdetermination -- Part II. Methods -- 9. A Millian Look at the Logic of Clinical Trials -- 10. "Learning by Difference: Placebo Effects and Specific Efficacy in Pharmacological RCTs" -- 11. "An Evidence-Hierarchical Decision Aid for Ranking in Evidence-Based Medicine" -- 12. "Assessing Drug Safety Assessment: Metformin Associated Lactic Acidosis" -- 13. Robust Biomarkers: Methodologically Tracking Causal Processes in Alzheimer’s Measurement -- 14. "Modelling Individual Response to Treatment and its Uncertainty: a Review of Statistical Methods and Challenges for Future Research" -- Part III. Decisions -- 15. Values in Pharmacology -- 16. "Humbug, the Council of Pharmacy and Chemistry, and the Origin of “the Blind Test” of Therapeutic Efficacy" -- 17. On the Normative Foundations of Pharmaceutical Regulation -- 18. After Disclosure -- 19. Sex, Drugs, and how to Deal with Criticism—The Case of Flibanserin. |
isbn |
3-030-29179-0 3-030-29178-2 |
issn |
0068-0346 ; |
callnumber-first |
R - Medicine |
callnumber-subject |
RM - Therapeutics and Pharmacology |
callnumber-label |
RM300 |
callnumber-sort |
RM 3300 U534 42020 |
illustrated |
Not Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
615 - Pharmacology & therapeutics |
dewey-full |
615.1 |
dewey-sort |
3615.1 |
dewey-raw |
615.1 |
dewey-search |
615.1 |
work_keys_str_mv |
AT lacazeadam uncertaintyinpharmacologyepistemologymethodsanddecisions AT osimanibarbara uncertaintyinpharmacologyepistemologymethodsanddecisions |
status_str |
n |
ids_txt_mv |
(CKB)4100000010473822 (MiAaPQ)EBC6121699 (DE-He213)978-3-030-29179-2 (oapen)https://directory.doabooks.org/handle/20.500.12854/71573 (EXLCZ)994100000010473822 |
carrierType_str_mv |
cr |
hierarchy_parent_title |
Boston Studies in the Philosophy and History of Science, 338 |
hierarchy_sequence |
338 |
is_hierarchy_title |
Uncertainty in Pharmacology Epistemology, Methods, and Decisions / |
container_title |
Boston Studies in the Philosophy and History of Science, 338 |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField noLinkedField |
_version_ |
1767578289856053248 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04861nam a22004575i 4500</leader><controlfield tag="001">993548246504498</controlfield><controlfield tag="005">20220713114653.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr#cnu||||||||</controlfield><controlfield tag="008">200220s2020 gw | o |||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-030-29179-0</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-030-29179-2</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000010473822</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)EBC6121699</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-He213)978-3-030-29179-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/71573</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000010473822</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RM300</subfield><subfield code="b">.U534 2020</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">HP</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED050000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">QD</subfield><subfield code="2">thema</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.1</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">La Caze, Adam</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Uncertainty in Pharmacology</subfield><subfield code="h">[electronic resource] :</subfield><subfield code="b">Epistemology, Methods, and Decisions /</subfield><subfield code="c">edited by Adam LaCaze, Barbara Osimani.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed. 2020.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Springer Nature</subfield><subfield code="c">2020</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham :</subfield><subfield code="b">Springer International Publishing :</subfield><subfield code="b">Imprint: Springer,</subfield><subfield code="c">2020.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (475 pages).</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Boston Studies in the Philosophy and History of Science,</subfield><subfield code="x">0068-0346 ;</subfield><subfield code="v">338</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This volume covers a wide range of topics concerning methodological, epistemological, and regulatory-ethical issues around pharmacology. The book focuses in particular on the diverse sources of uncertainty, the different kinds of uncertainty that there are, and the diverse ways in which these uncertainties are (or could be) addressed. Compared with the more basic sciences, such as chemistry or biology, pharmacology works across diverse observable levels of reality: although the first step in the causal chain leading to the therapeutic outcome takes place at the biochemical level, the end-effect is a clinically observable result—which is influenced not only by biological actions, but also psychological and social phenomena. Issues of causality and evidence must be treated with these specific aspects in mind. In covering these issues, the book opens up a common domain of investigation which intersects the deeply intertwined dimensions of pharmacological research, pharmaceutical regulation and the related economic environment. The book is a collective endeavour with in-depth contributions from experts in pharmacology, philosophy of medicine, statistics, scientific methodology, formal and social epistemology, working in constant dialogue across disciplinary boundaries.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Part I. Epistemology -- 1. Defining Aspects of Mechanisms: Evidence-Based Mechanism (Evidence for a Mechanism), Mechanism-Based Evidence (Evidence from a Mechanism), and Mechanistic Reasoning -- 2. Causal Insights from Failure: Post-Marketing Risk Assessment of Drugs as aWay to Uncover Causal Mechanisms -- 3. Extrapolating from Model Organisms in Pharmacology -- 4. "Mechanistic Versus Statistical Extrapolation in Preclinical Research in Psychiatry: Challenging the Received View" -- 5. Analogy-Based Inference Patterns in Pharmacological Research -- 6. "In Silico Clinical Trials: a Possible Response to Complexity in Pharmacology" -- 7. "Uncertainty in Drug Discovery: Strategies, Heuristics and Technologies" -- 8. “Caught in the Amber”: a Sketch of Chemical Underdetermination -- Part II. Methods -- 9. A Millian Look at the Logic of Clinical Trials -- 10. "Learning by Difference: Placebo Effects and Specific Efficacy in Pharmacological RCTs" -- 11. "An Evidence-Hierarchical Decision Aid for Ranking in Evidence-Based Medicine" -- 12. "Assessing Drug Safety Assessment: Metformin Associated Lactic Acidosis" -- 13. Robust Biomarkers: Methodologically Tracking Causal Processes in Alzheimer’s Measurement -- 14. "Modelling Individual Response to Treatment and its Uncertainty: a Review of Statistical Methods and Challenges for Future Research" -- Part III. Decisions -- 15. Values in Pharmacology -- 16. "Humbug, the Council of Pharmacy and Chemistry, and the Origin of “the Blind Test” of Therapeutic Efficacy" -- 17. On the Normative Foundations of Pharmaceutical Regulation -- 18. After Disclosure -- 19. Sex, Drugs, and how to Deal with Criticism—The Case of Flibanserin.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="536" ind1=" " ind2=" "><subfield code="a">H2020 European Research Council</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medicine—Philosophy.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical ethics.</subfield></datafield><datafield tag="650" ind1="1" ind2="4"><subfield code="a">Philosophy of Medicine.</subfield><subfield code="0">https://scigraph.springernature.com/ontologies/product-market-codes/E34030</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Theory of Medicine/Bioethics.</subfield><subfield code="0">https://scigraph.springernature.com/ontologies/product-market-codes/H66000</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Uncertainty Management in Pharmacology, Causality Medical Epistemology,</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-030-29178-2</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">LaCaze, Adam.</subfield><subfield code="e">editor.</subfield><subfield code="4">edt</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Osimani, Barbara.</subfield><subfield code="e">editor.</subfield><subfield code="4">edt</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Boston Studies in the Philosophy and History of Science,</subfield><subfield code="x">0068-0346 ;</subfield><subfield code="v">338</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-06-01 23:12:45 Europe/Vienna</subfield><subfield code="d">00</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2020-03-09 01:44:44 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5339633390004498&Force_direct=true</subfield><subfield code="Z">5339633390004498</subfield><subfield code="8">5339633390004498</subfield></datafield></record></collection> |